JP2007500171A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500171A5
JP2007500171A5 JP2006521581A JP2006521581A JP2007500171A5 JP 2007500171 A5 JP2007500171 A5 JP 2007500171A5 JP 2006521581 A JP2006521581 A JP 2006521581A JP 2006521581 A JP2006521581 A JP 2006521581A JP 2007500171 A5 JP2007500171 A5 JP 2007500171A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
aryl
alkenyl
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006521581A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500171A (ja
JP4908210B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/051625 external-priority patent/WO2005011686A1/en
Publication of JP2007500171A publication Critical patent/JP2007500171A/ja
Publication of JP2007500171A5 publication Critical patent/JP2007500171A5/ja
Application granted granted Critical
Publication of JP4908210B2 publication Critical patent/JP4908210B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006521581A 2003-07-28 2004-07-27 Pi3キナーゼ阻害剤として使用するための2−イミノ−4−(チオ)オキソ−5−ポリシクロビニルアゾリン類 Expired - Fee Related JP4908210B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03102313.8 2003-07-28
EP03102313 2003-07-28
PCT/EP2004/051625 WO2005011686A1 (en) 2003-07-28 2004-07-27 2-imino-4-(thio) oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors

Publications (3)

Publication Number Publication Date
JP2007500171A JP2007500171A (ja) 2007-01-11
JP2007500171A5 true JP2007500171A5 (https=) 2007-09-13
JP4908210B2 JP4908210B2 (ja) 2012-04-04

Family

ID=34112474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521581A Expired - Fee Related JP4908210B2 (ja) 2003-07-28 2004-07-27 Pi3キナーゼ阻害剤として使用するための2−イミノ−4−(チオ)オキソ−5−ポリシクロビニルアゾリン類

Country Status (9)

Country Link
US (1) US8106214B2 (https=)
EP (1) EP1648452B1 (https=)
JP (1) JP4908210B2 (https=)
CA (1) CA2531140C (https=)
DE (1) DE602004022170D1 (https=)
ES (1) ES2328146T3 (https=)
IL (1) IL173195A (https=)
NO (1) NO332434B1 (https=)
WO (1) WO2005011686A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718642A4 (en) * 2004-02-25 2010-11-24 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
MXPA06015028A (es) 2004-07-01 2007-02-08 Hoffmann La Roche Tiazolinas cinolinas no sustituidas.
CN101052640B (zh) * 2004-09-03 2011-05-11 默克雪兰诺有限公司 吡啶亚甲基唑烷酮类及其作为磷酸肌醇抑制剂的用途
US7241893B2 (en) 2004-09-17 2007-07-10 Hoffman-La Roche Inc. Thiazolinone 2-substituted quinolines
US7253285B2 (en) 2004-09-17 2007-08-07 Hoffmann-La Roche Inc. Thiazolinone 4-monosubstituted quinolines
CN101039939B (zh) * 2004-10-14 2010-07-07 霍夫曼-拉罗奇有限公司 作为cdk1抑制剂的喹唑啉基亚甲基噻唑啉酮类
US7304074B2 (en) * 2005-04-05 2007-12-04 Hoffmann-La Roche Inc. Substituted 1,5-naphthyridine azolinones
PE20070083A1 (es) * 2005-06-08 2007-01-27 Smithkline Beecham Corp (5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)amino]-1,3-tiazol-4(5h)-ona
CN101300047A (zh) * 2005-09-07 2008-11-05 雪兰诺实验室有限公司 Pi3k抑制剂用于子宫内膜异位症的治疗
US20080306057A1 (en) * 2005-10-11 2008-12-11 Laboratories Serono Sa P13K Inhibitors for the Treatment of Endometriosis
EP1976495A2 (en) * 2006-01-06 2008-10-08 Aarhus Universitet Compounds acting on the serotonin transporter
WO2007113005A2 (en) * 2006-04-03 2007-10-11 European Molecular Biology Laboratory (Embl) 2-substituted 3-aminosulfonyl-thiophene derivatives as aurora kinase inhibitors
CL2007000995A1 (es) * 2006-04-11 2008-06-27 Smithkline Beecham Corp Compuestos derivados de tiazolidinadiona; composicion farmaceutica; y uso para tratar uno o mas estados de enfermedad seleccionada entre trastornos autoinmunes, enfermedad inflamatoria, cardiovascular y neurodegenerativa entre otras.
US20100286041A1 (en) * 2007-03-22 2010-11-11 Smithkline Beecham Corporation (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
US20080255115A1 (en) * 2007-04-11 2008-10-16 Michael Gerard Darcy Thiazolidinedione derivatives as pi3 kinase inhibitors
PE20090288A1 (es) * 2007-05-10 2009-04-03 Smithkline Beecham Corp Derivados de quinoxalina como inhibidores de la pi3 quinasa
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
FR2919608B1 (fr) * 2007-08-01 2012-10-05 Univ Rennes Derives d'imidazolones,procede de preparation et applications biologiques
EP2255830A1 (en) 2008-03-03 2010-12-01 Takeda Pharmaceutical Company Limited Concomitant drug
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
MX2013000617A (es) * 2010-07-16 2013-06-13 Piramal Entpr Ltd Derivados sustituidos de imidazoquinolina como inhibidores de quinasa.
CN102584809B (zh) * 2011-01-14 2014-12-24 湘北威尔曼制药股份有限公司 胺基噻唑烷酮化合物及其制备方法与在制备抗肿瘤药物中的应用
US9745323B2 (en) 2012-07-30 2017-08-29 Kyoto University Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
US10310802B2 (en) * 2014-03-26 2019-06-04 Unanimous A. I., Inc. System and method for moderating real-time closed-loop collaborative decisions on mobile devices
CN106588909B (zh) * 2017-01-06 2019-08-27 广东工业大学 一种喹啉类衍生物的制备及其在抗炎中的应用
HRP20240793T1 (hr) 2018-04-18 2024-09-13 Constellation Pharmaceuticals, Inc. Modulatori enzima koji modificiraju metil, njihovi pripravci i upotreba
EP3797108B1 (en) 2018-05-21 2022-07-20 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
LT4003532T (lt) 2019-07-24 2024-11-11 Constellation Pharmaceuticals, Inc. 7-chlor-2- (4-(3-metoksiazetidin-1-il)cikloheksil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-okso-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioksol-5-karboksamido kristalinės formos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH052200A (ja) 1990-09-28 1993-01-08 Toshiba Corp 有機非線形光学材料
JP3871354B2 (ja) * 1994-07-29 2007-01-24 株式会社フジモト・コーポレーション 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
JP4782564B2 (ja) 2002-07-10 2011-09-28 メルク セローノ ソシエテ アノニム アゾリジノン−ビニル縮合−ベンゼン誘導体
CN100579978C (zh) * 2002-11-22 2010-01-13 史密丝克莱恩比彻姆公司 化合物
CN101052640B (zh) 2004-09-03 2011-05-11 默克雪兰诺有限公司 吡啶亚甲基唑烷酮类及其作为磷酸肌醇抑制剂的用途

Similar Documents

Publication Publication Date Title
JP2007500171A5 (https=)
EP1857446A4 (en) NEW HSP90 INHIBITOR
EP1938155A4 (en) BUSINESS PROCESS EXECUTE ENGINE
JP2007518723A5 (https=)
JP2005248180A5 (https=)
WO2007098030A8 (en) Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
JP2010520851A5 (https=)
JP2006507484A5 (https=)
JP2010500432A5 (https=)
JP2006506499A5 (https=)
FR2862761B1 (fr) Accelerometre differentiel micro-usine multiaxes
JP2005146110A5 (https=)
JP2008540542A5 (https=)
JP2008514710A5 (https=)
ATE483690T1 (de) Verfahren zur synthese von 5-(methyl-1h-imidazol- 1-yl)-3-(trifluormethyl)-benzeneamin
JP2007508806A5 (https=)
NO20081103L (no) 9-Aminoklarbonylsubstituerte derivater av glycylcykliner
JP2003284553A5 (https=)
JP2006501859A5 (https=)
JP2007308606A5 (https=)
FR2889815B3 (fr) Conduite d'admission.
EP1873240A4 (en) HTERT-GENE EXPRESSION regulatory gene
RU2003121211A (ru) Гетероциклические о-дикарбонитрилы
RU2002112201A (ru) Способ определения потенциальной урожайности зерновых колосовых культур
RU2004122075A (ru) N-(3-бутин-ил)-n-гидроксимочевина